New Research Reveals Age Plays Key Role in Cannabis‑Related Psychiatric Risks
New research highlights cannabis-related psychiatric risks adolescents face compared to adults. This study emphasizes the importance of age in evaluating cannabis's mental health impact. Clinicians should tailor screening and interventions accordingly.
Mississippi House Approves Senate Changes to Medical Cannabis Legislation
The Mississippi medical cannabis legislation update reflects recent changes agreed upon by the House and Senate. These modifications influence patient access and clinical practice parameters. Healthcare providers and patients should monitor these updates…
Germany’s Medical Cannabis Product Range Quadruples as Prices Fall 30%
Germany medical cannabis access expansion has led to a quadrupling of available products and a 30% price reduction. This growth enhances patient options and reduces cost barriers. The development offers insights into market dynamics affecting clinical…
Cannabidiol & Glucose Tolerance: Clinical Research Findings
This pilot study examined short-term low-dose cannabidiol supplementation and its effects on glucose tolerance. The findings showed no improvement in glucose tolerance or gut microbiome changes. Short-term low-dose cannabidiol use alone is unlikely to…
New Restrictions on THC-Infused Beverages in Ohio
THC-infused beverages restrictions in Ohio limit sales to licensed dispensaries, impacting patient access. These regulations aim to improve dosing accuracy and reduce risks. Clinicians should understand these changes to guide patients effectively.
Bill Regulating THC Edible Sales in SC Nears Gov. McMaster’s Desk
South Carolina THC edible regulation is advancing toward gubernatorial approval, promising clearer standards for product quality and dosing. This legislation will help clinicians better counsel patients on safe cannabis edible use. Improved regulation…
Push to Repeal New York Medical Cannabis Tax Amid ‘Crisis’ Claims
The New York medical cannabis tax repeal is a critical issue affecting patient access and affordability. This tax increases out-of-pocket costs, potentially reducing medication adherence. Clinicians should consider these financial barriers when…
Synergistic Neuroimmune Modulation by Cannabidiol and Probiotics for Therapeutic Advancement in CNS Disorders
This systematic review explores gut-brain axis cannabidiol probiotics synergy for neuroimmune modulation in CNS disorders. It highlights emerging evidence on combined CBD and probiotic effects. The review underscores the need for clinical validation of…
Virginia on the Verge of Recreational Cannabis Retail Sales
Virginia recreational cannabis retail sales are set to begin in 2027, marking a major regulatory shift. Clinicians should prepare for increased patient exposure and counseling needs. Understanding this change is essential for safe and informed clinical…
New Statewide Cannabis Restrictions Taking Effect Today in Ohio
New Ohio restrictions on marijuana and hemp THC products are taking effect today, impacting patient access and clinical decision-making. These statewide cannabis regulations reflect ongoing political tensions and failed ballot initiatives. Clinicians…